MUMBAI, India, Oct. 12 -- Intellectual Property India has published a patent application (202621096047 A) filed by Dr. Swati Devendra Raysing; Dr. Shailesh Subhashrao Chalikwar; Ms. Vaishnavi Surendra Tale; and Dr. Santosh Ramrao Butle on August 08, 2026, for A Pharmaceutical Composition Of Spanlastics In Situ Nasal Gel And Process Of Preparation Thereof.
Inventors include Dr. Swati Devendra Raysing; Dr. Shailesh Subhashrao Chalikwar; Ms. Vaishnavi Surendra Tale; and Dr. Santosh Ramrao Butle.
The application for the patent was published on October 09, 2026, under issue no. 41/2026.
Abstract: ABSTRACT A PHARMACEUTICAL COMPOSITION OF SPANLASTICS IN SITU NASAL GEL AND PROCESS OF PREPARATION THEREOF 5 10 The present invention relates to an in-situ nasal gel composition comprising duloxetine hydrochloride-loaded spanlastics for the intranasal delivery in the treatment of diabetic peripheral neuropathy. The composition exhibits enhanced physicochemical stability, improved storage stability and shelf life, sustained drug release, prolonged therapeutic action, and reduced dosing frequency, thereby providing an effective alternative to conventional oral and nasal dosage forms for the management of diabetic peripheral neuropathy.
Disclaimer: Curated by HT Syndication.
